As the leader in global life science supply chain management, Marken continues to be the forerunner for promoting industry trends and innovation as well as establishing international best practices. This has led to the formation of a strategic and technical board of global advisors.
This group has been hand-picked to provide Marken clients with evolving industry knowledge and perspectives for every aspect of the end to end Pharmaceutical Supply Chain. The internationally recognized experience of the advisory board positions Marken to provide consulting and leadership to its clients globally and will represent Marken as opinion leaders.
Advisory Board Members:
Rafik H. Bishara
Rafik H. Bisahra, PhD is the current Chair of the Pharmaceutical Cold Chain Interest Group (PCCIG) within the Parenteral Drug Association PDA) formerly Director, Quality Knowledge Management and Technical Support with Eli Lilly & Co. for 35 years.
Bishara has become one of the most respected figures in the pharmaceutical cold chain distribution sector, following a distinguished 35 year career with Eli Lilly & Co. as Director, Quality Knowledge Management and Technical Support
Dr. Bishara received his Ph.D. from Purdue University, Indiana, USA, adding to his B.S. Pharmacy & Pharmaceutical Chemistry and an M.S. Phytochemistry from Butler University, Indianapolis, USA
Dr. Bishara has authored numerous articles, and technically advised several organizations on Good Cold Chain and Temperature – Controlled Management.
Laurent Foetisch is Founder and Managing Director of Supply Chain Operations SA, formerly Vice President of Global Supply Chain for Merck Serono and Serono for over 20 years.
Laurent founded Supply Chain Operations SA in June 2011 to provide operational supply chain support to life science companies. Laurent has extensive experience as a supply chain executive responsible for managing a global biotech and pharmaceutical company in Switzerland for more than 20 years. After the acquisition of Serono by Merck KGaA. Laurent launched a three and an half year program to integrate the classical pharmaceutical supply chain of Merck and the biopharmaceutical supply chain of Serono to create one integrated value chain with common processes and tools.
Schooling: Villamont, Lausanne
College: Business School, Lausanne
Training: 6 Sigma, Business in China, Coaching for Peak Performance, IMD Lausanne
Alan Horgan is an independent consultant working with Whiteacres Associates LLC and formerly Group Vice President, Late Stage Development MDS Pharma Services and Corporate Senior Vice President & Global President of Clinical Development for Covance.
Alan Horgan is a seasoned healthcare professional with over 25 years experience of leadership in the Pharmaceutical and CRO Services arenas.
Mr. Horgan began his career at ER Squibb and Sons moving swiftly up through the ranks in Sales and Marketing. A year after the merger with Bristol – Myers he moved to Boots Pharmaceuticals and as Managing Director of the UK and Irish Pharmaceutical Companies, oversaw the launch of several new products in the cardiovascular and non steroidal inflammatory markets. He led the team that was to eventually license in Pantoprozole from German Pharmaceutical maker Byk Gulden.